Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 1, 2009
A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary diseaseDavid E Victorson, Susan Anton, Alan Hamilton, et al.Respiratory Medicine|December 10, 2013
Designing trials of behavioral interventions to increase physical activity in patients with COPD: insights from the chronic disease literatureNancy Kline Leidy, Miriam Kimel, Loni Ajagbe, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 7, 2016
Pharmacokinetics and safety of olodaterol administered with the Respimat Soft Mist inhaler in subjects with impaired hepatic or renal functionChristina Kunz, Doreen Luedtke, Anna Unseld, et al.Journal of Telemedicine and Telecare|March 27, 2013
Successful treatment of patients with hepatitis C in rural and remote Western Australia via telehealthSaroja Nazareth, Nickolas Kontorinis, Niroshan Muwanwella, et al.COPD|April 19, 2012
Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocolFrancesco Sava, Hélène Perrault, Cynthia Brouillard, et al.Respiratory Research|July 8, 2016
Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studiesFrançois Maltais, Anne-Marie Kirsten, Alan Hamilton, et al.Springerplus|September 5, 2014
The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studiesGregory J Feldman, Jonathan A Bernstein, Alan Hamilton, et al.International Journal of Chronic Obstructive Pulmonary Disease|July 22, 2014
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studiesAndrea Koch, Emilio Pizzichini, Alan Hamilton, et al.Journal of Ethnobiology and Ethnomedicine|November 30, 2018
Indigenous knowledge of dye-yielding plants among Bai communities in Dali, Northwest Yunnan, ChinaYanxiao Fan, Yanqiang Zhao, Aizhong Liu, et al.International Journal of Chronic Obstructive Pulmonary Disease|June 27, 2014
Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studiesGary T Ferguson, Gregory J Feldman, Peter Hofbauer, et al.Pageof 5